Zacks Small Cap Research on MSN
ARWR: Strong Start for REDEMPLO Commercialization…
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update First Commercial Sales of REDEMPLO® ...
If symptoms develop soon after taking a supplement, intolerance to supplement ingredients is also a possibility. Since ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...
Mediafeed on MSN
How to prep for blood & lab tests for best results
This article was reviewed by Felix Gussone, MD. Key Takeaways: Preparing properly for lab tests helps ensure your results are accurate and reliable. Some tests — … ...
5don MSN
This test may predict heart disease better than 'bad' cholesterol. Why aren't more getting it?
“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals ...
New research from King's College London suggests that a rapid blood testing method could deliver reliable results far more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results